Navigation Links
Michael L. Parks, MD, Elected to the American Academy of Orthopaedic Surgeons Board of Directors
Date:2/26/2009

LAS VEGAS, Feb. 26 /PRNewswire-USNewswire/ -- Orthopaedic surgeon Michael L. Parks, MD, was elected to the Board of Directors of the American Academy of Orthopaedic Surgeons (AAOS) (http://www.aaos.org/), at the 2009 Annual Meeting in Las Vegas. He will serve the Academy as Member-at-Large for the "under 45 year old" Board position.

Dr. Parks specializes in the reconstruction of arthritic conditions affecting the hip and knee. He is currently assistant attending orthopaedic surgeon at Hospital for Special Surgery and assistant professor of orthopaedic surgery at the Cornell Weill School of Medicine in New York.

After earning an undergraduate degree in Chemistry from Duke University in North Carolina, Dr. Parks graduated from the Medical University of South Carolina, in Charleston. Completing his internship in general and thoracic surgery, followed by an orthopaedic residency at Duke University Medical Center, Dr. Parks continued his training at Hospital for Special Surgery with a fellowship on the Hip and Knee Service.

"I am looking forward to the opportunity to serve on the Academy's Board of Directors," said Dr. Parks. "With the ever increasing demands from our aging population and decreasing resources, the Academy's role in advocacy and education becomes more important. It is my hope to bring the perspective of an urban practicing orthopaedist to the Board, while working to strengthen the reach of our organization."

As an Academy Fellow, Dr. Parks serves on the Board of Councilors and is past Chair of the Board of Councilors Bylaws Review Committee. He is also a member of the Leadership Development Committee. "Dr. Parks' ideas and perspectives are always well thought out, well expressed, and respectful of others who have differing opinions," said Thomas C. Barber, MD, Chair-Elect of the Academy's Board of Councilors.

Dr. Parks is an active member of the American Orthopaedic Association (AOA), the American Association of Hip and Knee Surgeons (AAHKS), and the J. Robert Gladden Orthopaedic Society. He is a guest reviewer for the Journal of Bone and Joint Surgery and is also the author of research papers and book chapters.

"With the constant changes evident in today's health care environment, it is essential that we as orthopaedic surgeons remain involved locally, in our individual medical centers and communities, as well as nationally to bolster our ability to perform our craft," notes Dr. Parks. "Only through our involvement will we advance ourselves and our ability to care for the patients whom we serve."

More about Dr. Parks

(http://www.hss.org/physicians_parks-michael.asp)

About AAOS

(http://www6.aaos.org/news/Pemr/releases/release_boiler.cfm?category=40&releasenum=735)

    For more information, contact:

    Catherine Dolf
    C (847) 894-9112
    O (847) 384-4034
    dolf@aaos.org

    Lauren L. Pearson
    C (224) 374-8610
    O (847) 384-4031
    lpearson@aaos.org




'/>"/>
SOURCE American Academy of Orthopaedic Surgeons
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. American TeleCare, Inc. (ATI) Appoints Michael A. Brodeur as Chief Financial Officer
2. Michael J. Fox Foundation Awards $1.9 Million for Development of Non-Invasive Neuroimaging Techniques in Living Brain
3. Former Health & Human Services Secretary Michael Leavitt To Address Health Plan Member Retention Summit
4. Former Health & Human Services Secretary Michael Leavitt to Address Health Plan Member Retention Summit
5. Michael J. Fox Foundation Awards $2.5 Million for Parkinsons Drug Development Projects Led By Academic Investigators
6. Suzanne Somers Appears on CNBCs Conversations with Michael Eisner and Discusses NeoStems Adult Stem Cell Collection Program
7. KineMatik Group Ltd. Appoints Michael G. Jarjour as President & CEO
8. Michael Kincaid Named Executive Vice President, Chief Financial Officer and Treasurer of HVHC Inc.
9. NYC Mayor Michael R. Bloomberg Declares January 8th IBREA Brain Education Day
10. Davis Vision, Inc. Names Michael Ehrle Divisional Vice President of Sales
11. DNA2.0 Expands European Presence By Opening UK Office: Experienced Life Sciences Executive, Dr. Michael Dyson, to Lead European Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... January 19, 2017 , ... Wells ... facility enhancement of their 503A compounding pharmacy located in Ocala, Florida. , ... physicians and patients throughout the United States for high-quality human anti-aging and ...
(Date:1/19/2017)... ... January 19, 2017 , ... This month, the CEO and ... name of their drug rehab center in Delray Beach, Florida has been changed from ... only stars such as Philip Seymour Hoffman and Chris Farley are dying from heroin ...
(Date:1/19/2017)... , ... January 19, 2017 , ... WhoHaha , ... up with the American Heart Association (AHA) to produce a three-part video series that ... will debut as part of the launch of AHA’s Healthy For Good™ movement, which ...
(Date:1/19/2017)... ... January 19, 2017 , ... Cosmetic Town, an online ... procedures in order to make it easier for their readers to get the information ... they impact as well as the techniques used on those particular areas. , “We ...
(Date:1/19/2017)... , ... January 19, 2017 , ... ... and development solutions for drugs, biologics and consumer health products, today announced that ... with Gattefossé, the leader in innovative excipients and drug delivery solutions to health ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... Calif. , Jan. 19, 2017  Abaxis, Inc. ... manufacturing point-of-care blood analysis instruments and consumables for the ... call to discuss its financial results for the third ... call will be at 4:15 p.m. ET on Thursday, ... for the third quarter fiscal year 2017 after the ...
(Date:1/19/2017)... , Jan. 19, 2017  Sensus Healthcare, ... device company specializing in the treatment of non-melanoma ... keloids, with superficial radiation therapy, today announced that ... year 2016 financial results on Thursday, February 2, 2017 ... will hold a conference call with the investment ...
(Date:1/19/2017)... , January 19, 2017 ... announced that the U.S. Food and Drug Administration (FDA) ... a New Drug Application (NDA) for SHP465, a long-acting, ... as a potential once-daily treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). ... or around June 20, 2017, the designated Prescription Drug ...
Breaking Medicine Technology: